EpitogenX provides a novel range of biologically active recombinant proteins for veterinary and human research, designed for functionality, stability, and experimental relevance.
Our product catalogue includes immune stimulants such as flagellins, cytokines, antimicrobial peptides, vaccine candidates, and disease biomarkers, supporting applications in diagnostics, therapeutics, and vaccine development.
We support the advancement of research and the development of diagnostics, therapeutics, and vaccine formulations through reliable and scalable recombinant protein production.
From sequence to purified protein, we design and construct expression vectors tailored to your target, enabling efficient production in optimised prokaryotic systems. Flexible purification strategies are applied based on your requirements, ensuring high yield and purity. Protein integrity and bioactivity are validated using in-house assay systems to confirm performance in downstream applications.
Recombinant protein production workflow
